Within the previous three months, 5 analysts have launched scores for Guardant Well being GH, presenting a big selection of views from bullish to bearish.
Within the desk under, you will discover a abstract of their latest scores, revealing the shifting sentiments over the previous 30 days and evaluating them to the earlier months.
| Bullish | Considerably Bullish | Detached | Considerably Bearish | Bearish | |
|---|---|---|---|---|---|
| Complete Rankings | 3 | 2 | 0 | 0 | 0 |
| Final 30D | 0 | 1 | 0 | 0 | 0 |
| 1M In the past | 2 | 0 | 0 | 0 | 0 |
| 2M In the past | 1 | 0 | 0 | 0 | 0 |
| 3M In the past | 0 | 1 | 0 | 0 | 0 |
Within the evaluation of 12-month value targets, analysts unveil insights for Guardant Well being, presenting a mean goal of $32.0, a excessive estimate of $44.00, and a low estimate of $28.00. Experiencing a 17.95% decline, the present common is now decrease than the earlier common value goal of $39.00.
Diving into Analyst Rankings: An In-Depth Exploration
In inspecting latest analyst actions, we acquire insights into how monetary specialists understand Guardant Well being. The next abstract outlines key analysts, their latest evaluations, and changes to scores and value targets.
| Analyst | Analyst Agency | Motion Taken | Ranking | Present Worth Goal | Prior Worth Goal |
|---|---|---|---|---|---|
| Mason Carrico | Stephens & Co. | Maintains | Chubby | $44.00 | – |
| Kyle Mikson | Canaccord Genuity | Lowers | Purchase | $30.00 | $45.00 |
| Alex Nowark | Craig-Hallum | Declares | Purchase | $28.00 | – |
| Matthew Sykes | Goldman Sachs | Lowers | Purchase | $28.00 | $32.00 |
| David Westenberg | Piper Sandler | Lowers | Chubby | $30.00 | $40.00 |
Key Insights:
- Motion Taken: Responding to altering market dynamics and firm efficiency, analysts replace their suggestions. Whether or not they ‘Preserve’, ‘Increase’, or ‘Decrease’ their stance, it signifies their response to latest developments associated to Guardant Well being. This provides perception into analysts’ views on the present state of the corporate.
- Ranking: Providing insights into predictions, analysts assign qualitative values, from ‘Outperform’ to ‘Underperform’. These scores convey expectations for the relative efficiency of Guardant Well being in comparison with the broader market.
- Worth Targets: Understanding forecasts, analysts provide estimates for Guardant Well being’s future worth. Inspecting the present and prior targets supplies perception into analysts’ altering expectations.
Understanding these analyst evaluations alongside key monetary indicators can provide invaluable insights into Guardant Well being’s market standing. Keep knowledgeable and make well-considered selections with our Rankings Desk.
Keep updated on Guardant Well being analyst scores.
Delving into Guardant Well being’s Background
Guardant Well being, Inc, primarily based in Redwood Metropolis, California, is a pacesetter in liquid-based most cancers assessments for medical and analysis use. The corporate provides Guardant360 LDT, a liquid biopsy take a look at for therapy choice in superior stage most cancers, Guardant360 CDx, an FDA-approved companion diagnostic for a number of focused therapies, and Guardant OMNI, a broader gene panel for immuno-oncology analysis. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual illness, or MRD, take a look at. In 2022, the corporate launched a lab-developed take a look at model of Protect, a liquid biopsy for colorectal most cancers, or CRC, screening. Moreover, Guardant provides analysis growth providers reminiscent of regulatory approval consultancy and medical trial referrals.
Monetary Insights: Guardant Well being
Market Capitalization Evaluation: Beneath business benchmarks, the corporate’s market capitalization displays a smaller scale relative to friends. This might be attributed to components reminiscent of progress expectations or operational capability.
Income Development: Guardant Well being’s income progress over a interval of three months has been noteworthy. As of 31 March, 2024, the corporate achieved a income progress price of roughly 30.9%. This means a considerable enhance within the firm’s top-line earnings. As in comparison with its friends, the corporate achieved a progress price greater than the typical amongst friends in Well being Care sector.
Internet Margin: Guardant Well being’s web margin lags behind business averages, suggesting challenges in sustaining sturdy profitability. With a web margin of -68.24%, the corporate might face hurdles in efficient price administration.
Return on Fairness (ROE): Guardant Well being’s ROE is under business requirements, pointing in direction of difficulties in effectively using fairness capital. With an ROE of -101.32%, the corporate might encounter challenges in delivering passable returns for shareholders.
Return on Belongings (ROA): Guardant Well being’s ROA lags behind business averages, suggesting challenges in maximizing returns from its belongings. With an ROA of -6.59%, the corporate might face hurdles in attaining optimum monetary efficiency.
Debt Administration: The corporate faces challenges in debt administration with a debt-to-equity ratio greater than the business common. With a ratio of 19.73, warning is suggested attributable to elevated monetary threat.
What Are Analyst Rankings?
Rankings come from analysts, or specialists inside banking and monetary methods that report for particular shares or outlined sectors (usually as soon as per quarter for every inventory). Analysts normally derive their data from firm convention calls and conferences, monetary statements, and conversations with essential insiders to achieve their selections.
Some analysts may also provide forecasts for metrics like progress estimates, earnings, and income to offer additional steerage on shares. Traders who use analyst scores ought to word that this specialised recommendation comes from people and could also be topic to error.
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
